Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review
Background Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physi...
Saved in:
Main Authors: | Spurling, Geoffrey K., Mansfield, Peter R., Montgomery, Brett D., Lexchin, Joel, Doust, Jenny, Othman, Noordin, Vitry, Agnes I. |
---|---|
格式: | Article |
語言: | English |
出版: |
Public Library of Science
2010
|
主題: | |
在線閱讀: | http://irep.iium.edu.my/346/1/journal.pmed.1000352.pdf http://irep.iium.edu.my/346/ http://dx.doi.org/10.1371/journal.pmed.1000352 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Quality of pharmaceutical advertisements in medical journals: a systematic review
由: Othman, Noordin, et al.
出版: (2009) -
Pharmaceutical promotion : the theoretical framework of regulation.
由: Othman, Noordin, et al.
出版: (2011) -
The challenge of pharmaceutical promotion regulation in Malaysia.
由: Othman, Noordin, et al.
出版: (2011) -
Prescribing of Strong Opioid Analgesics by UK Primary Care Physicians from 2000 to 2010
由: Zin, Che Suraya, et al.
出版: (2012) -
Prescribing of strong opioid analgesics by UK primary care physicians from 2000 to 2010
由: Zin, Che Suraya, et al.
出版: (2012)